The latent TB detection market is expected to reach US$ 1,684.86 million in 2027 from US$ 1,131.82 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027.
The growth of the market is attributed to the increasing prevalence of tuberculosis and government initiatives to promote tuberculosis detection. However, multidrug resistant tuberculosis (MDR-TB) is likely to hamper the growth of the Latent TB Detection market to a certain extent.
Lucrative Regional Markets for Latent TB Detection
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Government Initiatives to Promote Tuberculosis Detection
The disease disproportionally affects the poor, vulnerable, undernourished, and marginalized people worldwide. Evidence from various sources such as World Health Organization (WHO) and the United Nations (UN) shows that countries such as India and Indonesia in Asia Pacific are highly populated with patients suffering from TB. Thus, the government bodies in these countries are undertaking and adopting certain schemes and initiatives in containing the disease. For instance, the Indian National Strategic Plan (NSP) that aims for TB elimination has been established from 2017 to 2025; it institutes several patient support groups and protection measures along with the provision of free TB diagnostic tests and treatment for Indians. Furthermore, in March 2018, the Government of India, in association with the Directorate of General Health Services, introduced a new scheme known as “Nikshay Poshak Yojna” that included the provision of nutritional support for patients suffering with TB in India. Similarly, another scheme known as Direct Benefit Transfer (DBT) has been introduced for patients suffering from TB. This policy involves direct transfer of cash to the victim’s account intended for TB diagnostic tests, treatments, and medication costs.
Furthermore, western countries such as the US, the UK, and Canada are giving significant importance in combating TB by undertaking various funding programs. The US government is the largest donor of the Global Fund to fight AIDS, tuberculosis, and malaria. The US funding for global TB efforts was reported to be US$ 321 million in 2020. Thus, the financial and medical assistance from the governments for fighting the disease and promoting the diagnosis of TB is providing a lucrative scenario for the growth of the market.
Test-Based Insights
Based on test, the latent TB detection market was segmented into Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). In 2019, the Interferon Gamma Released Assay (IGRA) segment accounted for the highest share in the market and is likely to retain its dominant share. Also, the similar segment is expected to witness fastest growth in the market owing to the accuracy obtained through these tests. The IGRA test has numerous advantages over the TST of not needing the patient to return for test result evaluation. Current IGRAs do not cross-react with most non-TB mycobacteria, including Bacille Calmette-Guerin (BCG) strains.
Latent TB Detection Market, by Test – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User-Based Insights
Based on end user, the latent TB detection market is segmented into hospitals, diagnostic centers, laboratory and others. The hospitals segment held the largest share of the market in 2019. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Latent TB Detection Market: Strategic Insights
Market Size Value in US$ 1,131.82 Million in 2019 Market Size Value by US$ 1,684.86 Million by 2027 Growth rate CAGR of 5.2% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Latent TB Detection Market: Strategic Insights
| Market Size Value in | US$ 1,131.82 Million in 2019 |
| Market Size Value by | US$ 1,684.86 Million by 2027 |
| Growth rate | CAGR of 5.2% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The latent TB detection market players such as QIAGEN, BioMeriux S.A., F. Hoffmann La-Roche Ltd., BD, ARKRAY, Inc., Abbott, Serum Institute of India Pvt. Ltd, Oxford Immunotec Ltd, Lionex GmbH have been adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in September 2020, Oxford Immunotec received approval from the FDA to allow use of the T-SPOT.TB test in two years of age and older. This will help in meeting the pediatric patients needs for TB management
Latent TB Detection Market– by Test
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
Latent TB Detection Market– by End User
- Hospitals
- Diagnostic Centers
- Laboratories
- Others
Latent TB Detection Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East &Africa
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- QIAGEN
- BioMeriux S.A.
- F. Hoffmann La-Roche Ltd.
- BD
- ARKRAY, Inc.
- Abbott
- Serum Institute of India Pvt. Ltd
- Oxford Immunotec Ltd
- Lionex GmbH
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test and Interferon Gamma Released Assay ); End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Latent TB Detection Market – By Test
1.3.2 Latent TB Detection Market – By End User
1.3.3 Latent TB Detection Market – By Geography
2. Latent TB Detection Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Latent TB Detection Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 APAC – PEST Analysis
4.2.4 MEA – PEST Analysis
4.2.5 SCAM – PEST Analysis
5. Latent TB Detection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Tuberculosis
5.1.2 Government Initiatives to Promote Tuberculosis Detection
5.2 Market Restraints
5.2.1 Emergence of Multidrug Resistant Tuberculosis (MDR-TB)
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Advancements in Tuberculosis Diagnosis
5.5 Impact Analysis
6. Latent TB Detection Market – Global Analysis
6.1 Global Latent TB Detection Market Revenue Forecast And Analysis
6.2 Global Latent TB Detection Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Latent TB Detection Market Analysis – By Test
7.1 Overview
7.2 Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
7.4 Tuberculin Skin Test (TST)
7.4.1.1 Overview
7.4.1.2 Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Interferon Gamma Released Assay (IGRA)
7.5.1.1 Overview
7.5.1.2 Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8. Latent TB Detection Market Analysis – By End User
8.1 Overview
8.2 Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
8.4 Hospitals
8.4.1.1 Overview
8.4.1.2 Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.5 Diagnostic Centers
8.5.1.1 Overview
8.5.1.2 Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.5.2 Laboratories
8.5.2.1 Overview
8.5.2.2 Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.5.3 Others
8.5.3.1 Overview
8.5.3.2 Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
9. Latent TB Detection Market Analysis and Forecasts To 2027 – Geographical Analysis
9.1 North America: Latent TB Detection Market
9.1.1 Overview
9.1.2 North America: Latent TB Detection Market, - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Latent TB Detection Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.1.6 US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2 Europe: Latent TB Detection Market
9.2.1 Overview
9.2.2 Europe: Latent TB Detection Market, - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2.7 UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.7.3 UK: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2.8 France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.8.3 France: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2.9 Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2.10 Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.2.11 Rest of Europe: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.2.11.3 Rest of Europe: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.3 Asia Pacific: Latent TB Detection Market
9.3.1 Overview
9.3.2 Asia Pacific: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia Pacific Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia Pacific: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.3.6 China: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.3.6.3 China Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.3.7 Japan: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.3.7.3 Japan Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.3.8 India: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.3.8.3 India Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.3.9 South Korea: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.3.9.3 South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.3.10 Australia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.3.10.3 Australia Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.4 Middle East & Africa: Latent TB Detection Market
9.4.1 Overview
9.4.2 Middle East & Africa: Latent TB Detection Market - Revenue and Forecast to 2027 (US$ Million)
9.4.3 Middle East and Africa Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.4.6 Saudi Arabia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Latent TB Detection Market
9.5.1 Overview
9.5.2 South and Central America: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Latent TB Detection Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Latent TB Detection Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 QIAGEN
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bioMerieux SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Oxford Immunotec Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Lionex GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ARKRAY, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Serum Institute of India Pvt. Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 3. US: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 4. US: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 10. Europe: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. UK: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 14. UK: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 15. France: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 16. France: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Spain: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 20. Spain: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 23. Asia Pacific Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 25. China Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 26. China Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 27. Japan Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 28. Japan Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 29. India Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 30. India Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 33. Australia Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 34. Australia Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 35. Middle East and Africa Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 36. Middle East and Africa Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 37. Saudi Arabia Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 38. Saudi Arabia Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 39. UAE Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 40. UAE Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 41. South Africa Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 42. South Africa Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 43. South and Central America Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 44. South and Central America Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 45. Brazil Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 46. Brazil Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 47. Argentina Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)
Table 48. Argentina Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 49. Organic Developments Done By Companies
Table 50. Inorganic Developments Done By Companies
Table 51. Glossary of Terms, Latent TB Detection Market
LIST OF FIGURES
Figure 1. Latent TB Detection Market Segmentation
Figure 2. Latent TB Detection Market – By Geography
Figure 3. Global Latent TB Detection Market Overview
Figure 4. Tuberculin Skin Test (TST) Segment Held Largest Share of Latent TB Detection Market
Figure 5. Asia-Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Global Latent TB Detection Market, By Geography (US$ Million)
Figure 7. Global Latent TB Detection Market – Leading Country Markets (US$ Million)
Figure 8. Global Latent TB Detection Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. APAC PEST Analysis
Figure 12. MEA PEST Analysis
Figure 13. SCAM PEST Analysis
Figure 14. Latent TB Detection Market Impact Analysis of Drivers and Restraint
Figure 15. Global Latent TB Detection Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Latent TB Detection Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning of Key Players
Figure 18. Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
Figure 19. Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 20. Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 21. Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
Figure 22. Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 23. Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 24. Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. North America: Latent TB Detection Market, Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 29. US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. Europe: Latent TB Detection Market, Revenue and Forecast to 2027 (USD Million)
Figure 34. Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 35. Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Rest of Europe: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Asia Pacific: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 42. Asia Pacific Latent TB Detection Market Revenue and Forecast to 2027 (USD Million)
Figure 43. Asia Pacific: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 44. China: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Japan: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. India: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. South Korea: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Australia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Middle East & Africa: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 50. Middle East & Africa Latent TB Detection Market Revenue and Forecast to 2027 (USD Million)
Figure 51. Middle East & Africa: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 52. Saudi Arabia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. UAE: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. South Africa: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. South and Central America: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 56. South and Central America Latent TB Detection Market Revenue and Forecast to 2027 (USD Million)
Figure 57. South and Central America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 58. Brazil: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. Argentina: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Impact of COVID-19 Pandemic in North American Country Markets
Figure 61. Impact of COVID-19 Pandemic in European Country Markets
Figure 62. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 63. Impact Of COVID-19 Pandemic In Rest of the World Countries Market
Figure 64. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Latent TB Detection Market
- QIAGEN
- BioMeriux S.A.
- F. Hoffmann La-Roche Ltd.
- BD
- ARKRAY, Inc.
- Abbott
- Serum Institute of India Pvt. Ltd
- Oxford Immunotec Ltd
- Lionex GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Latent TB Detection Market
Apr 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)